Clinical Trial Update: Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of cyclophosphamide, carfilzomib, thalidomide, and dexamethasone for newly diagnosed active multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)
• Thalidomide (thalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma, Stage I Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-09-23